We are live on ! Find out more
NGEN

NervGen Pharma
NGEN

1 hedge funds and large institutions have $56K invested in NervGen Pharma in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NGEN Hedge Fund Activity: Q4 2025 in Review

1 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in NervGen Pharma (NGEN) for Q4 2025, worth a combined $56K.

Buyers outnumbered sellers: 1 fund opened new NGEN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held NervGen Pharma (NGEN) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $56K of NervGen Pharma stock for Q4 2025.
  • 1 fund opened new NervGen Pharma positions in Q4 2025 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2025.